电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

PKD2 抗体 (AA 680-968)

This anti-PKD2 antibody is a 兔 多克隆 antibody detecting PKD2 in ELISA, IHC 和 IF. Suitable for 人.
产品编号 ABIN7163836
发货至: 中国

Quick Overview for PKD2 抗体 (AA 680-968) (ABIN7163836)

抗原

See all PKD2 抗体
PKD2 (Polycystic Kidney Disease 2 (Autosomal Dominant) (PKD2))

适用

  • 69
  • 45
  • 13
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1

宿主

  • 74
  • 3
  • 1

克隆类型

  • 76
  • 3
多克隆

标记

  • 48
  • 4
  • 4
  • 4
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This PKD2 antibody is un-conjugated

应用范围

  • 46
  • 40
  • 14
  • 13
  • 13
  • 11
  • 11
  • 8
  • 6
  • 5
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
  • 抗原表位

    • 15
    • 8
    • 8
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 680-968

    交叉反应

    纯化方法

    >95%, Protein G purified

    免疫原

    Recombinant Human Polycystin-2 protein (680-968AA)

    亚型

    IgG
  • 应用备注

    Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,

    限制

    仅限研究用
  • 状态

    Liquid

    缓冲液

    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

    储存液

    ProClin

    注意事项

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    储存条件

    -20 °C,-80 °C

    储存方法

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 抗原

    PKD2 (Polycystic Kidney Disease 2 (Autosomal Dominant) (PKD2))

    别名

    PKD2

    背景

    Background: Functions as a cation channel involved in fluid-flow mechanosensation by the primary cilium in renal epithelium (PubMed:18695040). Functions as outward-rectifying K(+) channel, but is also permeable to Ca(2+), and to a much lesser degree also to Na(+) (PubMed:11854751, PubMed:15692563, PubMed:27071085, PubMed:27991905). May contribute to the release of Ca(2+) stores from the endoplasmic reticulum (PubMed:11854751, PubMed:20881056). Together with TRPV4, forms mechano- and thermosensitive channels in cilium (PubMed:18695040). PKD1 and PKD2 may function through a common signaling pathway that is necessary to maintain the normal, differentiated state of renal tubule cells. Acts as a regulator of cilium length, together with PKD1. The dynamic control of cilium length is essential in the regulation of mechanotransductive signaling. The cilium length response creates a negative feedback loop whereby fluid shear-mediated deflection of the primary cilium, which decreases intracellular cAMP, leads to cilium shortening and thus decreases flow-induced signaling. Also involved in left-right axis specification via its role in sensing nodal flow, forms a complex with PKD1L1 in cilia to facilitate flow detection in left-right patterning. Detection of asymmetric nodal flow gives rise to a Ca(2+) signal that is required for normal, asymmetric expression of genes involved in the specification of body left-right laterality (By similarity).

    Aliases: APKD2 antibody, Autosomal dominant polycystic kidney disease type II antibody, Autosomal dominant polycystic kidney disease type II protein antibody, MGC138466 antibody, MGC138468 antibody, PC 2 antibody, PC2 antibody, PKD 2 antibody, PKD2 antibody, PKD2_HUMAN antibody, PKD4 antibody, Polycystic kidney disease 2 (autosomal dominant) antibody, Polycystic kidney disease 2 antibody, Polycystic kidney disease 2 protein antibody, Polycystin 2 antibody, Polycystin 2 transient receptor potential cation channel antibody, Polycystin-2 antibody, Polycystin2 antibody, Polycystwin antibody, R48321 antibody, Transient receptor potential cation channel subfamily P member 2 antibody, TRPP2 antibody

    UniProt

    Q13563

    途径

    cAMP Metabolic Process, Maintenance of Protein Location, Negative Regulation of Transporter Activity
You are here:
Chat with us!